Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome: the dal-gene trial

Jean-Claude Tardif; MA Pfeffer; Wouter J. Jukema; Marie Pierre Dube; Fabrice FMAC Martens as PI WCN on behalf of the DAL-GENE Investigators

Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome: the dal-gene trial

Jean-Claude Tardif
, MA Pfeffer
, Wouter J. Jukema
, Marie Pierre Dube
, FMAC Martens as PI WCN on behalf of the DAL-GENE Investigators

University of Montreal
Leiden University

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Journal	European heart journal
Volume	43
Issue number	39
Publication status	Published - 14 Oct 2022

Cite this

@article{de8ef38911434fa696c71c5c362a7c42,

title = "Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome: the dal-gene trial",

author = "Jean-Claude Tardif and MA Pfeffer and Jukema, \{Wouter J.\} and Dube, \{Marie Pierre\} and \{FMAC Martens as PI WCN on behalf of the DAL-GENE Investigators\}",

year = "2022",

month = oct,

day = "14",

language = "English",

volume = "43",

journal = "European heart journal",

issn = "0195-668X",

publisher = "Oxford University Press",

number = "39",

}

TY - JOUR

T1 - Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome: the dal-gene trial

AU - Tardif, Jean-Claude

AU - Pfeffer, MA

AU - Jukema, Wouter J.

AU - Dube, Marie Pierre

AU - FMAC Martens as PI WCN on behalf of the DAL-GENE Investigators, null

PY - 2022/10/14

Y1 - 2022/10/14

M3 - Article

SN - 0195-668X

VL - 43

JO - European heart journal

JF - European heart journal

IS - 39

ER -